Jorge Manuel Aldea Saldana

Jorge Manuel Aldea Saldana

Auto-generated profile, based on publicly available information

Jorge Manuel Aldea Saldana

Faculty of Health Sciences, Peruvian University of Applied Sciences , Av. Prolongacón Primavera 2390, Santiago de Surco, Lima 15023

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2026 in Current Cardiology Reviews
Verified
Journal Article
Closed access
SBSunchandandeep Singh Brar
Sunchandandeep Singh Brar
MYMeenakshi Reddy Yathindra
Meenakshi Reddy Yathindra
JAJuan Sebastian Arias Arango
Juan Sebastian Arias Arango
EGErika Aguirre Gutierrez
Erika Aguirre Gutierrez
FAFawaz Aldoohan
Fawaz Aldoohan
VDVyapti Dave
Vyapti Dave
Heart Failure (HF) is a prevalent medical illness worldwide that affects millions and is a substantial economic burden. Its epidemiological impact is on the rise due to factors such as the ageing of the population, increasing rates of diabetes and hypertension, and better survival post-myocardial infarction. Some limitations in HF management include diagnostic challenges, sudden progression of the disease, and rising rates of readmission. Continuous monitoring and limited therapeutic interventions add further complexity to care. Artificial Intelligence(AI) is essential in health care and has provided solutions for improving HF management. Techniques like machine learning and deep learning enhance clinical decision-making and patient care. AI helps physicians diagnose HF more precisely through the analysis of imaging and electrocardiograms. Additionally, the patients' risk is calculated using various AI algorithms to develop personalized treatments for each individual. AI will help healthcare providers identify problems early and select appropriate therapies, leading to better outcomes. Further areas for improvement include enhanced data integration, predictive accuracy, patient engagement, data privacy and ethics, as well as integration with clinical workflows. AI technologies will continue to evolve in managing and treating HF; ongoing exploration and development are crucial for its optimization. This review outlines the current progress and potential of AI in the future to ensure better patient care and healthcare practices.

30 September 2026 in European Heart Journal - Case Reports
Verified
Journal Article
Open access
MSMaicol Augusto Cortez Sandoval
Maicol Augusto Cortez Sandoval
MPMilagros Palomino
Milagros Palomino
DHDayana Hernandez
Dayana Hernandez
JSJorge M Aldea Saldaña
Jorge M Aldea Saldaña
OROscar Rodríguez-Fernández
Oscar Rodríguez-Fernández
Background: Pulmonary artery intimal sarcoma is an exceptionally rare and aggressive malignancy that can closely mimic pulmonary embolism. Overlapping clinical and imaging features frequently lead to diagnostic anchoring and delayed recognition, with devastating prognostic consequences. Case summary: A 50-year-old woman presented with a nine-month history of progressive dyspnoea and cough and was admitted with hypotension, jugular venous distension, peripheral oedema, and systolic murmurs. Laboratory testing revealed a D-dimer level of 0.5 μg/mL (reference range 0.1–0.6 μg/mL). Transthoracic echocardiography showed right ventricular dilatation and a mass involving the pulmonary valve and main pulmonary artery. Computed tomography pulmonary angiography demonstrated an expansile lesion of the main pulmonary artery extending into both branches, with extraluminal involvement and new pulmonary nodules. Despite therapeutic anticoagulation for presumed pulmonary embolism, there was no clinical or radiological improvement. Histological diagnosis was obtained through biopsy of a breast lesion, revealing a high-grade sarcoma with vascular differentiation consistent with pulmonary artery intimal sarcoma. Given extensive local invasion and poor functional status (ECOG 4), curative treatment was not feasible, and the patient died 30 days after definitive diagnosis. Discussion: In the present case, pulmonary artery intimal sarcoma should be considered in patients with an atypical or refractory pulmonary embolism phenotype, particularly when a normal D-dimer level accompanies progressive pulmonary artery obstruction. Diagnostic clues include lack of response to anticoagulation, an expansile rather than occlusive intraluminal lesion, and extraluminal extension. Early recognition allows timely referral to specialized centres, which is critical given the poor prognosis once advanced local invasion has developed.